Early pregnancy hyperglycaemia among pregnant women with risk factors for gestational diabetes increases the risk of pregnancy complications.
Complication
Diabetes
Diagnosis
Early onset
Gestational
Management
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
received:
25
04
2024
accepted:
14
10
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
The current diagnostic criteria for gestational diabetes (GDM) were based on data from women after 24 weeks of gestation, but this may not be equally applicable for earlier gestation. There is insufficient data regarding early pregnancy glycaemia and the associated complications. We retrospectively reviewed 39,483 deliveries and 12,918 with risk factors for GDM underwent oral glucose tolerance test (OGTT) before 24 weeks of gestation. A strong and progressively positive association was observed with any pregnancy complications in both fasting glucose (FG) and 2 h glucose (2hG). The increased risk of developing any pregnancy complications started from FG 4.5-4.7 mmol/L and 2hG of 6.2-6.9mmol/L. Every increase by 1 mmol/L in FG or 2 hG levels increased the risk of developing any complications (aOR 1.614 for FG and 1.131 for 2hG), pre-eclampsia (aOR 1.472 for FG and 1.143 for 2hG), maternal insulin use (aOR 12.821 for FG and 2.366 for 2hG), primary Caesarean section(aOR 1.274 for FG and 1.099 for 2hG), shoulder dystocia (aOR 1.941 for FG and 1.282 for 2hG), macrosomia(aOR 2.203 for FG and 1.072 for 2hG), and large for gestation age(aOR 2.157 for FG and 1.074 for 2hG). Therefore, glycaemic levels in early pregnancy among high-risk women positively associated with pregnancy complications, even at levels below the current recommended diagnostic criteria for GDM.
Identifiants
pubmed: 39448754
doi: 10.1038/s41598-024-76497-5
pii: 10.1038/s41598-024-76497-5
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
25157Informations de copyright
© 2024. The Author(s).
Références
McIntyre, H. D. et al. Gestational diabetes mellitus. Nat. Rev. Dis. Primers 5(1), 47 (2019).
doi: 10.1038/s41572-019-0098-8
pubmed: 31296866
World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. https://apps.who.int/iris/bitstream/handle/10665/85975/WHO_NMH_MND_13.2_eng.pdf (2013).
O’Sullivan, J. B. & Mahan, C. M. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13, 278–285 (1964).
pubmed: 14166677
Crowther, C. A. et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352(24), 2477–2486 (2005).
doi: 10.1056/NEJMoa042973
pubmed: 15951574
Landon, M. B. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 361(14), 1339–1348 (2009).
doi: 10.1056/NEJMoa0902430
pubmed: 19797280
pmcid: 2804874
Group, H. S. C. R. et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358(19), 1991–2002 (2008).
doi: 10.1056/NEJMoa0707943
International Association of D, Pregnancy Study Groups et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676–682 (2010).
doi: 10.2337/dc09-1848
Farrar, D. et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 354, i4694 (2016).
doi: 10.1136/bmj.i4694
pubmed: 27624087
pmcid: 5021824
Immanuel, J. & Simmons, D. Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and Meta-analysis. Curr. Diab Rep. 17(11), 115 (2017).
doi: 10.1007/s11892-017-0943-7
pubmed: 28971305
Zhu, W. W. et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36(3), 586–590 (2013).
doi: 10.2337/dc12-1157
pubmed: 23193214
pmcid: 3579369
Simmons, D. et al. Treatment of gestational diabetes mellitus diagnosed early in pregnancy. N. Engl. J. Med. 388(23), 2132–2144 (2023).
doi: 10.1056/NEJMoa2214956
pubmed: 37144983
Roeder, H. A., Moore, T. R., Wolfson, M. T., Gamst, A. C. & Ramos, G. A. Treating hyperglycemia in early pregnancy: a randomized controlled trial. Am. J. Obstet. Gynecol. MFM 1(1), 33–41 (2019).
doi: 10.1016/j.ajogmf.2019.03.003
pubmed: 33319755
Harper, L. M. et al. Early gestational diabetes screening in obese women: a randomized controlled trial. Am. J. Obstet. Gynecol. 222(5), 495 (2020).
doi: 10.1016/j.ajog.2019.12.021
pmcid: 7196002
McIntyre, H. D. et al. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care 39(1), 53–54 (2016).
doi: 10.2337/dc15-1887
pubmed: 26519336
Papachatzopoulou, E. et al. Abnormal fasting, post-load or combined glucose values on oral glucose tolerance test and pregnancy outcomes in women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 161, 108048 (2020).
doi: 10.1016/j.diabres.2020.108048
pubmed: 32027925
Riskin-Mashiah, S., Younes, G., Damti, A. & Auslender, R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32(9), 1639–1643 (2009).
doi: 10.2337/dc09-0688
pubmed: 19549728
pmcid: 2732138
Punnose, J., Sukhija, K. & Rijhwani, R. M. Intermediate hyperglycemia in early pregnancy: a south Asian perspective. World J. Diabetes 14(5), 573–584 (2023).
doi: 10.4239/wjd.v14.i5.573
pubmed: 37273252
pmcid: 10236988
Wang, C. et al. Evaluation of the value of fasting plasma glucose in the first trimester for the prediction of adverse pregnancy outcomes. Diabetes Res. Clin. Pract. 174, 108736 (2021).
doi: 10.1016/j.diabres.2021.108736
pubmed: 33705819
Ye, Y., Xiong, Y., Zhou, Q., Xiao, X. & Li, X. Early-pregnancy intermediate hyperglycemia and adverse pregnancy outcomes among women without gestational diabetes. J. Clin. Endocrinol. Metab. 107(4), e1541–e1548 (2022).
doi: 10.1210/clinem/dgab841
pubmed: 34850011
Bender, W. R., McCarthy, C., Elovitz, M., Parry, S. & Durnwald, C. Adverse pregnancy outcomes in nondiabetic patients with an elevated early pregnancy HbA1c. Am. J. Perinatol. 29(14), 1496–1502 (2022).
doi: 10.1055/a-1877-8696
pubmed: 35709738
Cheung, K. W. et al. Hemoglobin A1c in early pregnancy to identify preexisting diabetes mellitus and women at risk of hyperglycemic pregnancy complications. AJOG Glob. Rep. 4(1), 100315 (2024).
doi: 10.1016/j.xagr.2024.100315
pubmed: 38362048
pmcid: 10867763
Farrar, D. et al. Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the born in Bradford cohort. Lancet Diabetes Endocrinol. 3(10), 795–804 (2015).
doi: 10.1016/S2213-8587(15)00255-7
pubmed: 26355010
pmcid: 4673084